Equity · Healthcare
MYGN
NASDAQMyriad Genetics (MYGN)
The line runs 5.83 USD on 23 October through 5.91 USD on 6 November, on a scale from 5.75 to 6.75. Days the market did not trade hold the previous close, flat.
- Market cap
- 566.4M USD
- Revenue, year to Dec 2025
- 824.5M USD
- EPS, diluted, year to Dec 2025
- −3.95 USD
- 52-week range
- 3.54 USD – 8 USD
- Avg volume
- 329.3K
- Mentions, 30 days
- 1
as of Nov 6, 2026
Have Myriad Genetics (MYGN) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, no Myriad Genetics insider bought or sold shares on the open market; all 5 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 9 Nov 2026, newest Form 4 filing 1 Nov 2026
Buys 0Sells 0Other filings 5
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Nov 2026 | Fox Jennifer LynneChief Legal & Corp Strategy | Award | 39,370 | |
| 21 Sep 2026 | Wheeler Benjamin RichardChief Financial Officer | Tax withheld | 2,555 | 10K USD |
| 16 Sep 2026 | Sikri VishalEVP, Commercial | Award | 257,731 | |
| 03 Sep 2026 | Fox Jennifer LynneChief Legal Officer | Tax withheld | 4,398 | 14K USD |
| 16 Aug 2026 | Wheeler Benjamin RichardChief Financial Officer | Tax withheld | 8,761 | 27K USD |
Which funds hold Myriad Genetics (MYGN)?
10 of the 45 institutional funds we track reported a Myriad Genetics position for the quarter ended 30 Jun 2026 — a combined 111.4M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Held (±25%) | 6,620,372 | 37.8M USD | −0.7% |
| D. E. Shaw & Co. | Held (±25%) | 4,582,083 | 26.2M USD | +1.8% |
| AQR Capital Management | Added | 2,766,689 | 15.8M USD | +44.7% |
| Two Sigma Investments | Held (±25%) | 1,557,727 | 8.9M USD | +21.3% |
| Citadel Advisors | Added | 1,533,684 | 8.8M USD | +238.5% |
| Marshall Wace | Held (±25%) | 1,222,804 | 7.0M USD | +10.8% |
| Man Group | Added | 908,733 | 5.2M USD | +226.6% |
| Point72 Asset Management | Trimmed | 238,776 | 1.4M USD | −75.1% |
| Tudor Investment Corp | Held (±25%) | 44,680 | 255K USD | −1.8% |
| Balyasny Asset Management | New position | 36,860 | 210K USD |
What has been filed or recorded for Myriad Genetics (MYGN)?
The filings we hold for Myriad Genetics, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 07 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,270 shares | 5K USD notional · 0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.46 USD | |
| 30 Sep 2026 | Financials | Total assets | 609.2M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 269.0M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.46 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.36 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −3.95 USD | |
| 31 Dec 2025 | Financials | Revenue | 824.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −365.9M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −3.95 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.29 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −3.57 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.00 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.41 USD |
What is Reddit saying about Myriad Genetics (MYGN)?
Reddit mentioned MYGN 1 times in the 30 days to 8 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 1Communities 1
How do Reddit mentions of Myriad Genetics (MYGN) compare with its price?
Share ↗
Where Myriad Genetics (MYGN) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.08 |
Myriad Genetics (MYGN): frequently asked questions
What did Myriad Genetics shares close at?
Myriad Genetics closed at 5.91 USD on 6 Nov 2026, down 6.12% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Myriad Genetics’ market cap?
Myriad Genetics is worth 566.4M USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Myriad Genetics’ revenue?
Myriad Genetics reported revenue of 824.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Myriad Genetics insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, no Myriad Genetics insider bought or sold shares on the open market; all 5 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Myriad Genetics?
10 of the 45 funds we track reported a Myriad Genetics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, D. E. Shaw & Co. and AQR Capital Management. See Funds
When did Myriad Genetics last report earnings?
Myriad Genetics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.46 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Myriad Genetics?
Myriad Genetics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings